CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Keylynk-013:A phase 3 study of pembrolizumab in combination with concurrent chemoradiation therapy followed by pembrolizumab with or without olaparib versus concurrent chemoradiation therapy in patients with newly diagnosed limited-stage SCLC.
Author
Byers LA
Califano R
+10Â more
Cho BC
Faivre-Finn C
Jabbour SK
Kato T
Lai WVV
Pietanza MC
Rimner A
Yu JM
Yu L
Zhao B
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
20/05/2021
Field of study
No full text
The University of Manchester - Institutional Repository